Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: bioprinting – Page 11

“One of the biggest roadblocks to generating functional tissue replacements has been our inability to print the complex vasculature that can supply nutrients to densely populated tissues,” said Jordan Miller, assistant professor at Rice University in the US.

“Further, our organs actually contain independent vascular networks — like the airways and blood vessels of the lung or the bile ducts and blood vessels in the liver,” Miller said.

“These interpenetrating networks are physically and biochemically entangled, and the architecture itself is intimately related to tissue function. Ours is the first bioprinting technology that addresses the challenge of multi vascularisation in a direct and comprehensive way,” he said.

Read more

The cosmos are filled with roughly Earth-sized exoplanets. Various moons, comets, and planets have stores of water, organic molecules, and amino acids like those that make up life on Earth.

Cathal O’Donnell, a 3D bioprinting researcher at St. Vincent’s Hospital in Melbournethose odds — he argues in The Conversation that the abundance of potentially habitable worlds out there makes the discovery of extraterrestrial life “inevitable and possibly imminent.”

Read more

In an effort to scale up the manufacture of biomaterials, researchers at UC Berkeley have combined bioprinting, a robotic arm, and flash freezing in a method that may one day allow living tissue, and even whole organs, to be printed on demand. By printing cells into 2D sheets and then freezing them as assembled, the new technique improves cell survival during both building and storage.

Read more

(3D-printed heart scaffold)

As the head of the University of Illinois Urbana-Champaign’s innovative Cancer Center, Bhargava has been plugging away at injecting more advanced engineering solutions into medical problems. The freeform 3D printer is one of the first futuristic achievements of that effort.

But Bhargava’s project is just one of a wave of technologies that stand to transform medicine and healthcare as we know it; to make them faster, more accurate, and hopefully, drastically more affordable. Microneedle patches, handheld diagnostic machines, and better sensing capabilities, as well as 3D bioprinting, are just a few of the technologies coming to a doctor’s office near you—or maybe even into your home—in the next decade.

Read more

Korean researchers have been experimenting further in the bioprinting of tracheal implants, publishing recent results in ‘Trachea with Autologous Epithelial Cells and Chondrocytes.’ The team of scientists details their use of polycaprolactone and hydrogel mixed with nasal epithelial and auricular cartilage cells.

After bioprinting an artificial trachea with these materials and tissue, they transplanted them into 15 rabbits, six of which were a control group. The goal was to find a way to overcome tracheal problems due to tumors, the most common of which are adenoid cystic carcinomas and squamous cell carcinomas. Previously there have been substantial challenges in creating viable tracheas that are anatomically correct and can produce a ciliated epithelium. Issues have arisen with infection, implants that become dislodged, have migrated, or experienced obstruction.

Read more

United Therapeutics will license, develop, and commercialize CollPlant Holdings’ recombinant human collagen (rhCollagen) and BioInk technology for 3D bioprinting of solid-organ scaffolds for human transplants, the companies said today, through a collaboration that could generate more than $44 million.

Through its wholly- owned organ manufacturing and transplantation-focused subsidiary Lung Biotechnology PBC, United Therapeutics has been granted what the companies termed an exclusive license “throughout the universe” by CollPlant to its technology for producing and using rhCollagen-based BioInk for 3D bioprinted lung transplants.

Lung Biotechnology PBC is a public benefit corporation formed to address the acute national shortage of transplantable lungs and other organs with a variety of technologies that either delay the need for such organs or expand the supply.


Medical research has taken a leap into the future as Russian scientists have managed to grow a mouse’s thyroid in zero gravity using a 3D bioprinter on the International Space Station (ISS). And human organs may be next in line.

The breakthrough device dubbed Organaut was delivered to the ISS by a Soyuz MS-11 spacecraft on December 3 by Expedition 58.

In what is no longer a plot of a sci-fi movie, the innovative device created a mouse’s thyroid in zero gravity. And the result was a success. Invitro, whose subsidiary 3D Bioprinting Solutions built the printer, told Ria Novosti: “We received photos from space. The camera clearly shows a living construction of a mouse’s thyroid being assembled.”

Read more

3D bioprinting continues to diversify as more and more companies and research organizations join the field, each bringing their own take on the technology to the table. French collaborative platform 3D.fab has an intriguing approach towards bioprinting that involves a freeform robot capable of directly printing on a part of the body. In the video below, the BioAssemblyBot prints what appears to be a bandage directly on an arm:

The “bandage” is actually a bio-ink made from the skin cells of a patient. When applied to the patient’s skin, it forms an autograft that will, within a couple of weeks, create new skin. The BioAssemblyBot is capable of both additive and contour 3D printing, as well as pick and place and assembly thanks to its interchangeable tools. It’s only one of 3D.fab’s bioprinting technologies; the platform has a few other bioprinters in development as well, including another skin printer.

Read more